Recent News

• 06.02.2026 - BullFrog AI Announces New Commercial Leadership Team to Execute Growth Strategy for its Integrated Pharma AI Platform
• 04.22.2026 - BullFrog AI Regains Compliance with Nasdaq Shareholders’ Equity Requirement
• 04.14.2026 - BullFrog AI Announces Participation at AACR Annual Meeting
• 04.13.2026 - BullFrog AI Provides Business Update: Strengthened Balance Sheet Supports Continued Execution as Company Aims to Ramp Commercial Activity with Global Pharmaceutical and Biotechnology Partners
• 03.30.2026 - BullFrog AI Announces Commercial Agreement with Top 5 Global Pharmaceutical Company to Identify and Prioritize Therapeutic Target in Major Depressive Disorder
• 03.25.2026 - BullFrog AI Unveils bfARENAS™ Scenario-based Decision Engine

Recent Filings

• 05.29.2026 - S-1 General form for registration of securities under the Securities Act of 1933
• 05.14.2026 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.01.2026 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.30.2026 - DEF 14A Other definitive proxy statements
• 04.22.2026 - 8-K Current report
• 04.22.2026 - EX-99.1 EX-99.1
• 04.21.2026 - 8-K Current report
• 04.13.2026 - EX-99.1 EX-99.1
• 04.13.2026 - 8-K Current report
• 04.01.2026 - 424B5 Prospectus [Rule 424(b)(5)]